Inspira Technologies Oxy B.H.N. Ltd. (IINN) - Market Cap to Earnings

Corporate emblem and logo of Inspira Technologies (IINN)

The price action of Inspira Technologies Oxy (IINN) reflects a current PE ratio of -1.20. Inspira Technologies Oxy is optimizing the assembly of complex life-support devices through automation, thereby reducing staffing costs. The business is developing alternatives to ventilators via minimally invasive blood oxygenation as part of its R&D. Meanwhile, the implementation of proprietary ART systems in intensive care units creates a sustainable technological lock-in for clinics to the vendor's solutions.

Inspira Technologies Oxy B.H.N. Ltd. (IINN): Price to Earnings Ratio from 09/18/2022 to 05/20/2026

Comprehensive metric breakdowns and analytics for inspira-technologies.com (IINN)

Manufactured product of Inspira Technologies Oxy

Inspira Technologies Oxy is currently transitioning to the mass production of medical equipment, rendering its cash flows dependent on certification. The P/E ratio trend reflects the relationship between the business's market value and its net income, allowing for an assessment of the investment payback period and the risk of asset overvaluation. Analysis of this chart helps determine the company's fundamental stability amid volatile earnings.

Analysis of competing companies

Dexcom - Market Cap to Net Income|Price to Earnings Ratio PEN (Penumbra Inc)|NOVT - Market Cap to Earnings|Haemonetics Corp. - Price to Earnings Ratio|P/E Multiple Inspire Medical Systems, Inc. INSP|PRCT: Price to Earnings Ratio|CONMED - Market Price to Net Income Ratio|PLSE: P/E Multiple|INMD - Business Payback Period|Price to Earnings Ratio PMI|Price to Earnings Ratio Surmodics (SRDX)|Price to Earnings Ratio SENS (Senseonics Holdings, Inc.)|NPCE (NeuroPace Inc) - Company Value to Net Income|Price to Earnings Ratio Tactile Systems Technology TCMD|SNWV - Price to Earnings Ratio|outsetmedical.com - P/E Multiple|Market Cap to Earnings smartvest.com|LNSR: P/E Multiple|Price to Earnings Multiple RCEL|PROF (Profound Medical) - P/E Multiple|Baird Medical Investment (BDMD) - Business Payback Period|P/E Multiple EDAP|Price to Earnings Ratio Apyx Medical Corporation APYX|P/E Multiple ICCM (IceCure Medical Ltd.)|P/E Multiple Pulmonx Corporation LUNG|TELA - Price to Earnings Ratio|CTSO: Price to Earnings Ratio|SRTS (Sensus Healthcare, Inc.) - Price to Earnings Ratio|Zynex, Inc. - Company Value to Net Income|ECOR (electroCore Inc) - P/E Multiple|Market Cap to Earnings vicarioussurgical.com RBOT|Price to Earnings Ratio ICU (SeaStar Medical Holding Corporation)|IRIDEX Corp. (IRIX) - Market Cap to Net Income Ratio|Intelligent Bio Solutions Inc - Price to Earnings Ratio|P/E Multiple AINostix XAIR|Profusa Inc. - P/E Multiple|Business Payback Period STRATA Skin Sciences, Inc. SSKN|GlucoTrack (GCTK) - Price to Earnings Ratio|Market Cap to Net Income NAOV (NanoVibronix Inc.)|Price to Earnings Ratio venusconcept.com|Price to Earnings Ratio Nuwellis, Inc. (NUWE)|P/E Multiple AEMD|ASXC - Market Cap to Earnings|Price to Earnings Ratio Avinger, Inc. AVGR|BSGM: Price to Earnings Multiple|CUTR: Price to Earnings Ratio|KNW - P/E Multiple|NARI: P/E Multiple|Price to Earnings Multiple NVRO|RSLS (ReShape Lifesciences, Inc.) - P/E Multiple|Silk Road Medical Inc (SILK) - Business Payback Period